연구성과로 돌아가기

2021 연구자 정보 (744 / 1146)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Kim, Ah Reum
(Kim, AR) ⓘ 		Seoul Natl Univ Hosp, Biomed Res Inst, Prote Core Facil, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 35.6] Lighthouse in the open sea of spastic ataxia; what are the features that should not be missed in SPG11? ⓘ SCIE ⓘ 35.6 CLINICAL NEUROLOGY ⓘ massive@cnuh.co.kr; ⓘ
Kim, Hyo Jae
(Kim, HJ) ⓘ 		Univ Ulsan, Asan Med Ctr, Coll Med, Dept Neurol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 35.6] Nocturnal stridor in multiple system atrophy: Video-polysomnography and clinical features ⓘ SCIE ⓘ 35.6 CLINICAL NEUROLOGY ⓘ sjchung@amc.seoul.kr; ⓘ
Kim, Kiju
(Kim, K) ⓘ 		Good Light Hosp, Dept Neurol, Gwangju, South Korea ⓘ
ⓘ 		0000-0002-0404-4612
Kim, Kiju ⓘ 		[JCR상위 35.6] Nocturnal stridor in multiple system atrophy: Video-polysomnography and clinical features ⓘ SCIE ⓘ 35.6 CLINICAL NEUROLOGY ⓘ sjchung@amc.seoul.kr; ⓘ
Kim, Mi-Jung
(Kim, MJ) ⓘ 		Bobath Mem Hosp, Dept Neurol, Seongnam, South Korea ⓘ
ⓘ 		0000-0001-9097-2759
Kim, Mi-Jung ⓘ 		[JCR상위 35.6] Nocturnal stridor in multiple system atrophy: Video-polysomnography and clinical features ⓘ SCIE ⓘ 35.6 CLINICAL NEUROLOGY ⓘ sjchung@amc.seoul.kr; ⓘ
Kim, Nayoung K. D.
(Kim, NKD) ⓘ 		Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 35.6] Lighthouse in the open sea of spastic ataxia; what are the features that should not be missed in SPG11? ⓘ SCIE ⓘ 35.6 CLINICAL NEUROLOGY ⓘ massive@cnuh.co.kr; ⓘ
Kim, Seung Joon
(Kim, SJ) ⓘ 		Catholic Univ, Seoul St Marys Hosp, Seoul, South Korea
Catholic Univ Korea, Coll Med, Canc Res Inst, Div Pulmonol,Dept Internal Med, Seoul, South Korea
Catholic Univ, Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea ⓘ 		AAK-1840-2021
JDC-5061-2023
Kim, Yong-Joo
Kim, Jung Oh ⓘ 		0000-0003-4836-8958
Kim, Seung Joon ⓘ 		[JCR상위 35.6] Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea
[JCR상위 59.9] Clinical impact of rebiopsy among patients with epidermal growth factor receptor-mutant lung adenocarcinoma in a real-world clinical setting
[JCR상위 43.1] Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations: Results from a real-world study in South Korea ⓘ 		SCIE ⓘ 35.6 ONCOLOGY;RESPIRATORY SYSTEM
ONCOLOGY ⓘ 		jangtw226@hanmail.net;jangtw22@hanmail.net;
ccm@amc.seoul.kr;
jangtw22@hanmail.net; ⓘ
Kim, Young Jin
(Kim, YJ) ⓘ 		Best Heals Hosp, Dept Neurol, Ansan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 35.6] Nocturnal stridor in multiple system atrophy: Video-polysomnography and clinical features ⓘ SCIE ⓘ 35.6 CLINICAL NEUROLOGY ⓘ sjchung@amc.seoul.kr; ⓘ
Lee, Kye Young
(Lee, KY) ⓘ 		Konkuk Univ, Med Ctr, Seoul, South Korea
Konkuk Univ, Dept Pulm Med, Sch Med, Seoul, South Korea
Konkuk Univ, Med Ctr, Dept Internal Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 35.6] Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea
[JCR상위 59.9] Clinical impact of rebiopsy among patients with epidermal growth factor receptor-mutant lung adenocarcinoma in a real-world clinical setting
[JCR상위 43.1] Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations: Results from a real-world study in South Korea ⓘ 		SCIE ⓘ 35.6 ONCOLOGY;RESPIRATORY SYSTEM
ONCOLOGY ⓘ 		jangtw226@hanmail.net;jangtw22@hanmail.net;
ccm@amc.seoul.kr;
jangtw22@hanmail.net; ⓘ
Lee, Sang-Ahm
(Lee, SA) ⓘ 		Univ Ulsan, Asan Med Ctr, Coll Med, Dept Neurol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea
Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea
Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, 88,Olymp Ro 43 Gil, Seoul 138736, South Korea ⓘ 		J-2778-2012
Lee, Dong ⓘ 		0000-0002-6743-0545
Lee, Sang-Ahm ⓘ 		[JCR상위 35.6] Nocturnal stridor in multiple system atrophy: Video-polysomnography and clinical features
[JCR상위 44.3] Insomnia moderates the association between recurrent seizures and emotional instability in persons with epilepsy
[JCR상위 44.3] Sex differences in seizure effects on social anxiety in persons with epilepsy ⓘ 		SCIE ⓘ 35.6 CLINICAL NEUROLOGY
BEHAVIORAL SCIENCES;CLINICAL NEUROLOGY;PSYCHIATRY ⓘ 		sjchung@amc.seoul.kr;
salee@amc.seoul.kr; ⓘ
Lee, Sung Yong
(Lee, SY) ⓘ 		제1저자 Korea Univ, Guro Hosp, Seoul, South Korea
Korea Univ, Coll Med, Dept Internal Med, Div Pulm Allergy & Crit Care Med,Guro Hosp, Seoul, South Korea
Korea Univ, Guro Hosp, Dept Internal Med, Div Pulmonol Allergy & Crit Care Med, Seoul, South Korea
Korea Univ, Dept Internal Med, Guro Hosp, Seoul, South Korea ⓘ 		ADE-2110-2022
GRR-7154-2022
Lee, Joo Yong
Lee, Hyoungjin ⓘ 		0000-0002-8693-5792
LEE, SUNG YONG ⓘ 		[JCR상위 35.6] Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea
[JCR상위 59.9] Clinical impact of rebiopsy among patients with epidermal growth factor receptor-mutant lung adenocarcinoma in a real-world clinical setting
[JCR상위 43.1] Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations: Results from a real-world study in South Korea
[JCR상위 48.4] Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05 ⓘ 		SCIE ⓘ 35.6 ONCOLOGY;RESPIRATORY SYSTEM
ONCOLOGY ⓘ 		jangtw226@hanmail.net;jangtw22@hanmail.net;
ccm@amc.seoul.kr;
jangtw22@hanmail.net;
oncologykang@naver.com; ⓘ
Moon, Sunghwan.
(Moon, S) ⓘ 		교신저자 Kyungpook Natl Univ, Dept Math, Daegu 41566, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 35.6] Singular value decomposition of the attenuated conical Radon transform with a fixed central axis and opening angle ⓘ SCIE ⓘ 35.6 MATHEMATICS, APPLIED;MATHEMATICS ⓘ sunghwan.moon@knu.ac.kr; ⓘ
Oh, Eungseok
(Oh, E) ⓘ 		교신저자 Chungnam Natl Univ, Sch Med, Dept Neurol, Chungnam Natl Univ Hosp, Daejeon, South Korea ⓘ AAL-8935-2020
Oh, Eungseok ⓘ
ⓘ 		[JCR상위 35.6] Lighthouse in the open sea of spastic ataxia; what are the features that should not be missed in SPG11? ⓘ SCIE ⓘ 35.6 CLINICAL NEUROLOGY ⓘ massive@cnuh.co.kr; ⓘ
Park, Woong-Yang
(Park, WY) ⓘ 		Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea
Sungkyunkwan Univ, Dept Mol Cell Biol, Sch Med, Suwon, Gyeonggi Do, South Korea
Samsung Med Ctr, Samsung Genome Inst, Seoul 06351, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 35.6] Lighthouse in the open sea of spastic ataxia; what are the features that should not be missed in SPG11?
[JCR상위 11.5] A nonsense TMEM43 variant leads to disruption of connexin-linked function and autosomal dominant disorder ⓘ 		SCIE ⓘ 11.5 CLINICAL NEUROLOGY
MULTIDISCIPLINARY SCIENCES ⓘ 		massive@cnuh.co.kr;
fengyong_hn@hotmail.com;cjl@ibs.re.kr;choiby2010@gmail.com; ⓘ
Ryu, Jeong Seon
(Ryu, JS) ⓘ 		Inha Univ Hosp, Incheon, South Korea
Inha Univ Hosp, Dept Internal Med, Incheon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 35.6] Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea
[JCR상위 43.1] Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations: Results from a real-world study in South Korea ⓘ 		SCIE ⓘ 35.6 ONCOLOGY;RESPIRATORY SYSTEM
ONCOLOGY ⓘ 		jangtw226@hanmail.net;jangtw22@hanmail.net;
jangtw22@hanmail.net; ⓘ
Yang, Sei Hoon
(Yang, SH) ⓘ 		Wonkwang Univ Hosp, Iksan, South Korea
Wonkwang Univ Hosp, Dept Internal Med, Iksan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 35.6] Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea
[JCR상위 43.1] Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations: Results from a real-world study in South Korea ⓘ 		SCIE ⓘ 35.6 ONCOLOGY;RESPIRATORY SYSTEM
ONCOLOGY ⓘ 		jangtw226@hanmail.net;jangtw22@hanmail.net;
jangtw22@hanmail.net; ⓘ
페이지 이동: